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Abstract
Background: Fair prioritization of healthcare resources has been on the agenda for decades, but resource allocation
dilemmas in clinical practice remain challenging. Can clinical ethics committees (CECs) be of help? The aim of the
study was to explore whether and how CECs handle priority setting dilemmas and contribute to raising awareness of
fairness concerns.
Method: Descriptions of activities involving priority setting in annual reports from Norwegian CECs (2003-2015) were
studied and categorized through qualitative content analysis.
Results: Three hundred thirty-nine reports from 38 CECs were studied. We found 78 activities where resource use or
priority setting were explicitly highlighted as main topics. Of these, 29 were seminars or other educational activities, 21
were deliberations on individual patient cases, whereas 28 were discussions of principled or general cases. Individual
patient cases concerned various distributional dilemmas where values were at stake. Six main topics and seven roles
for the CEC were identified. CECs handle issues concerning the introduction of new costly drugs, extraordinarily costly
established treatment, the application of priority setting criteria, resource use for vulnerable groups, resource
constraints compromising practice, and futility of care. The CEC can act as an analyst, advisor, moderator,
disseminator, facilitator, watch dog, and guardian of values and laws.
Discussion: In order to fulfil their responsibilities in handling priority setting cases, CECs need knowledge of
both the ethics and the institutionalized systems of priority setting. There is potential for developing this
aspect of the CECs’ work further.
Conclusions: The Norwegian CECs are involved in priority setting decisions where they can play multiple
constructive roles. In particular, they advise and raise awareness of ethical aspects in resource allocations;
bridge clinical practice with higher-level decisions; and promote fair resource allocation and stakeholder rights
and interests.
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Background
Although the most influential priority setting decisions
are made at the political level when healthcare budgets
are allocated, priority setting takes place at all levels of
the healthcare services. Priority setting can be implicit
or explicit [1, 2]. Priority setting ranks services according
to their importance and will therefore, by necessity, de-
termine the distribution of services in a way that creates
“winners” and “losers” [3]. Apparently, both politicians,
hospital managers and clinicians are reluctant to be the
ones who have to turn down patient requests for expen-
sive healthcare services [4].
The moral impact of distribution decisions has for de-
cades lead theorists to call for greater transparency and
reasonableness when allocating insufficient healthcare
resources [5]. The Scandinavian countries have been at the
forefront of the international endeavour of systematic prior-
ity setting processes at a policy level [6, 7]. Even for affluent
countries health expenditure rises in a way that threatens
to overwhelm the publicly financed health system. In
Norway, a set of priority setting criteria have been regulat-
ing policy and practice through specific laws and
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regulations. There have also been strategies to conduct le-
gitimate and transparent priority setting processes at the
macro level, such as the establishment of The National
Council for Priority Setting in Health Care [8]. The 2016
white paper on priority setting in Norway presented a re-
vised list of priority setting criteria (“utility”, “resource use”,
and “severity”), and there was a substantial call for more in-
volvement of stakeholders and stewards of the regulations
in priority setting decisions at all levels of the health care
system [9]. One of the specific actors the government
called upon was the hospital CECs. According to the
white paper, the CECs should contribute to the iden-
tification and open discussion of priority setting di-
lemmas at the clinical level.
In Norway, each health trust – comprising one or more
hospitals and providing specialized (secondary and ter-
tiary) healthcare – is required to have at least one CEC, of
which there are currently 37 in total. Norwegian CECs
have an advisory role only without any decision-making
authority. Traditionally, CECs have discussed ethical chal-
lenges related to concrete clinical situations concerning
one or more patients, held seminars for staff and contrib-
uted to the development of guidelines. Typical cases have
concerned treatment-limiting decisions, communication
and confidentiality, patient autonomy and the use of coer-
cion [10]. However, lately the Norwegian CECs have also
taken on more principled and general issues, so that issues
of what can be broadly termed organizational ethics now
comprise a sizeable proportion of cases [11, 12]. Inter-
nationally it is debated whether organizational ethics
requires a different venue than the CEC as the latter’s
traditional focus and primary competence is in clinical
ethics [13]. However, the Norwegian experience is that the
CEC, as a multiprofessional body with competence in law
and ethics and a patient representative, can be well suited
also for discussing organizational ethics, thereby helping
to bridge the gap between clinicians and hospital manage-
ment [11].
CECs are trained in analysing and discussing clinical-
ethical dilemmas together with all stakeholders in a sys-
tematic way following a specific deliberation method
[14] in order to promote openness about value judg-
ments and justifications in daily clinical practice. CECs
could therefore be thought to be helpful also in improv-
ing priority setting decisions and making these more
explicit and transparent [15, 16]. Priority setting decisions
involve weighing different interests, as do CEC
deliberations on clinical-ethical dilemmas. We are un-
aware of any studies of how CECs are involved in priority
setting issues at a hospital level and what roles they can
have on the path to fairer distribution of health resources.
Since 2011 the Norwegian CEC system has been regu-
lated through a national mandate issued by the Ministry
of Health and Care Services.1 Importantly, according to
the mandate one of the tasks is to “contribute to
increased understanding of the relationship between
clinical-ethical issues and questions related to resource
management and priorities in the health trusts”.
Through an inquiry to the European Clinical Ethics Net-
work we learned that Norway is most likely the only
European country where CECs have been mandated to
work with priority setting specifically. This makes a
study of relevant CEC activities in Norway particularly
relevant. Our objective is therefore to assess whether
and how the Norwegian CECs have worked with issues
of priority setting and resource use, and which issues
have been addressed.
Methods
Qualitative content analysis was performed in accord-
ance with common norms for such analysis [17]. Cod-
ing and categorization was informed by the researchers’
pre-formed understanding of the field of clinical prior-
ity setting and of CECs’ functions in other contexts. All
available annual reports from the Norwegian CECs for
the time period 2003-2015 – 339 in total – were
assessed by two researchers (MM and RF) independ-
ently. The annual reports detail the CECs’ activities to
some extent, yet do not provide identifying details
about patients or health professionals involved in the
clinical-ethical cases. All activities in which resource
use, rationing or priority setting were explicitly men-
tioned as main concerns were registered and coded
with regard to content. Tentative topics were then con-
structed inductively on the basis of the codes. The
topics were discussed among the researchers and then
revised.
For some cases thought to have been particularly illus-
trative, the original, anonymized case reports were ob-
tained upon a request to the CEC. Together with the
material from the annual reports, this content was coded
according to which functions or roles the CECs were
seen to exhibit when handling the cases described.
Drawing on experience with CECs in other contexts yet
mainly inductively from the present data, one researcher
(IM) drafted the list and description of roles, which were
then discussed among the researchers repeatedly, and
revised. For the sake of giving the reader a sense of the
CECs’ actual – and diverse – modes of operation some
of the cases are presented in the Results section. These
particular cases have been chosen because they concern
a broad set of priority setting topics, illustrate the CEC’s
different roles and were thought to be cases in which
the CEC’s efforts made a difference for practice. In one
sense, therefore, they are “success stories” and not ne-
cessarily representative for the entire set of cases in our
material.
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According to the Norwegian system, formal research
ethics approval was not required for this work as the
annual reports analyzed are publicly available material
and as the case reports received from the CECs were an-
onymous. As the cases presented in the Results section
have been very thoroughly anonymized we have deemed
consent to publish from patients, next of kin and clini-
cians not to be required.
Results
We found 78 activities where resources and/or priority
setting were explicitly highlighted as main topics. Of
these, 29 were seminars or other educational activities,
21 were deliberations on individual patient cases,
whereas 28 were discussions of principled or general
cases. In the annual reports, some activities were de-
scribed extensively or in some detail, whereas others
were only supplied as brief descriptions or even some-
times just as titles.
CEC activities were categorized in six (partially over-
lapping) topics. The topics and examples of each are
presented in Table 1.
Our analysis of the cases also led to the identification
of seven roles and responsibilities assumed by the CECs.
The roles and their potential impact are shown in
Table 2.
Below, five example cases illustrating the CECs’ work
and roles and some of the topics are presented in some
detail.
Extraordinarily costly treatment and futility of care: home
ventilator treatment (case A)
A patient with a degenerative disease had been living at
home dependent on ventilator treatment for years. The
large team of nurses required was very costly for the
municipality which footed the bill; thus, the municipal
authorities wanted the patient to move into a nursing
home. The patient and spouse resisted this, arguing that
the patient’s quality of life depended heavily on being
able to stay at home.
The CEC was asked if a patient could demand that
care was provided at home instead of in a nursing home;
the latter arrangement would entail significant savings.
A team of CEC members went to the patient’s house to
discuss, and the opinions of patient and spouse were
noted. Later the CEC arranged a meeting where many
stakeholders participated in a discussion on fair use of
resources and the conflicting considerations of patient
autonomy and justice in this case. Municipality repre-
sentatives stressed how the resource use influenced
other patients in need, with, for instance, a shortage of
home-care nurses. The CEC followed a structured delib-
eration method for ensuring that the stakeholders were
heard and relevant information was gathered. In a com-
plementary report to all the involved stakeholders the
CEC used a structured set-up and referred in detail to
the information presented to the committee, the trade-
off between values and principles, the national priority
setting criteria, and the legal limitation of the patient’s
right to claim treatment lacking substantial proven bene-
fits. The committee advised the municipality to offer
care in the nursing home only. The patient’s need for
quality of care and improved communication was also
acknowledged. The municipal health professionals and
authorities found the meeting and report useful and
reported that it made it easier for them to make a deci-
sion and abide by it.
Extraordinarily costly treatment for a vulnerable group:
access to experimental drugs for psychosis (case B)
A patient was severely affected by chronic psychosis of a
subtype which does not respond to ordinary anti-
psychotic drugs, and was hospitalized. The condition,
including the ability to communicate and cooperate, im-
proved substantially when an experimental drug was
tried. Due to this treatment, the patient went from a
Table 1 Topics related to resource issues treated in seminars (S), individual patient case discussions (I), and principled/general case
discussions (P)
Topics Examples
Introduction of new costly drugs New, costly drug for cystic fibrosis (P); co-payment for expensive drugs (I + P)
Extraordinarily costly established/
existing treatment
Costly treatment for patient with rare condition (I); home ventilator treatment (I); costly drug for serious
and rare psychiatric disease (I); requirements for patient conduct and compliance when treatment is
particularly expensive (I)
Application of priority criteria Age limits for lung transplantation (P); triage in the emergency department (P); Caesarean section “on
demand” (S); priority setting in rehabilitation medicine (S); discussion of national priority setting criteria (S)
Resource use for potentially
vulnerable groups
Illegal immigrant with serious chronic disease and repeated admissions (I); repeated cardiac surgery for
substance abusers (P); priority setting when medical evidence is scarce (P)
Budget/resource constraints
compromising good practice
The incompatible logics of “care” and “production” (S); reductions in staff and number of beds leading to
poorer services (P); transfer of imminently dying patients to nursing homes (P); early discharge from
hospital due to resources constraints (I)
Futility of care Expensive life-prolonging treatment with questionable benefits (I); priority setting in intensive care (S)
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state of continuous suffering to a more acceptable qual-
ity of life. However, the drug was expensive, and the
request for public financing was turned down by the
Norwegian Health Economics Administration (HELFO).
The CEC discussed the case and recommended that
public funds cover the costs because of the great bur-
dens of the disease for the patient, for the family and for
the healthcare system. In addition, the CEC argued that
the costs of the drug should not be viewed in isolation
from the significant savings; the patient’s improvement
led to reduced need of care personnel and therefore re-
duced personnel expenses. Furthermore, as the patient
group in question was small, total societal costs would
remain low even if the decision to treat would create
precedence. Chronic psychosis patients constitute a
weak societal group; this also counts in favour of higher
priority, according to the CEC. The CEC’s report was
submitted alongside a successful appeal to HELFO.
Priority setting and resource use for vulnerable groups:
valve replacement surgery for intravenous drug users
(case C)
Recently, a hospital had had several patients with intra-
venous drug use (IVDU) and endocarditis in need of a
second cardiac valve replacement surgery. There were
different opinions on whether this surgery should be pri-
oritized as it is expensive, recurrence risk is high, and
few manage to end their substance abuse. International
and national guidance was lacking. The CEC invited
relevant stakeholders and worked on the case for a long
time. By using a model for systematic analysis, the com-
mittee made explicit many of those considerations
decision-makers were confronted with when facing such
choices. The discussion illustrated not only the import-
ance of solid evidence for making a well-considered
choice, but also the necessity of clarifying the values and
principles that have an impact on priorities. Based on
the principle of equal treatment and expected survival,
the committee found that this group of patients should
receive the same treatment as other patients for whom a
corresponding treatment effect is expected. The majority
of the committee members were of the opinion that this
group should be offered surgery irrespective of whether
the substance abuse was likely to persist after the sur-
gery, giving less weight to the contested priority criterion
of responsibility for own disease state. The discussion in
the CEC lead to a change in hospital policy: before, all
IVDU patients in need of second replacement surgery
were declined surgery; now the decision is made on an
individual basis.
Introduction of new costly drugs: Immunotherapy and
patient co-payment (case D)
The CEC was contacted by a clinician working with pa-
tients with metastatic lung cancer. A new drug based on
immunotherapy had shown some effect for this group.
Yet the drug was very expensive with yearly costs at
€130,000, and the effect modest, providing 3 months
increased survival on average. The national decision-
making authorities (“Beslutningsforum”) had not con-
cluded if the costs should be covered by the hospital
budgets. Now, some patients wanted to buy the drug
themselves and requested to have the drug administered
by the hospital (as biweekly injections), and the doctor
asked the CEC for advice in how to respond. Such a
practice would be unprecedented in Norway’s publically
funded healthcare system and hospitals. In this city at
that time, no private clinics would offer to administer
the treatment. Several stakeholders were consulted. The
committee concluded that the principle of equal access
is fundamental in the Norwegian health care system, and
therefore it is not acceptable that only those who are
able to pay should receive the drug as patients within a
public hospital. The clinician was glad to have clearer ar-
guments and support in the committee – and, subse-
quently, hospital management – when he had to turn
down the patients’ requests. The patients were not satis-
fied, and some protested in the media. The CEC’s pro-
posed policy, however, was recently reiterated in the
government white paper on priority setting [9]. The
committee found it necessary to bring the dilemma to a
national level: when a drug has been proven effective
and safe and a national-level evaluation of coverage is
Table 2 Roles and possible impact of CECs dealing with priority issues
Role Potential impact Exemplified by cases
Analyst Clarify values/principles at stake and the impact of decisions A, B, C, D, E
Advisor Solve concrete dilemmas A, C, D, E
Moderator Contribute to fairer decision-making processes A, B, C, D
Disseminator Create awareness and disseminate knowledge among clinicians A, C, E
Coordinator Connect different levels of healthcare organizations B, D, E
Watch dog Recognize unfair prioritizations and alert relevant authorities B, E
Guardian of values and laws Ensure legitimacy and fairness in line with common values D, E
Magelssen et al. BMC Medical Ethics  (2017) 18:68 Page 4 of 8
underway, what should be done in the meantime? There
will be many similar situations in the future. The CEC
thus referred the case for a discussion in the National
council for priority setting. At the time of publishing the
Council has commenced preliminary discussions on the
case.
Budget constraints compromising good practice: a
“waiting list scandal” (case E)
A CEC at a large hospital discussed a case which in the
media had been presented as a scandal. According to
Norwegian regulations, patients on waiting lists for
medical treatment must be given a deadline tailored
to the individual for when treatment is to commence.
If treatment has not begun on the specified date, the
patient may complain. If treatment then is not com-
menced quickly, the patient is entitled to treatment at
other healthcare trusts or abroad, with the original
hospital footing the bill. In order to avoid excessive
costs, some departments at the hospital in question
prioritized expedite treatment for the patients who
complained about missed deadlines. Those who did
not complain, however, were left to wait longer, and
the fear was that this group was, in effect, unfairly
given low priority. General complaints about these
practices from the staff to the management were not
followed up.
The hospital’s CEO referred the case to the CEC and
took part in the CEC’s discussion. The CEC stressed that
most likely resourceful patients capable of advancing
their rights and of complaining had here been advan-
taged, relative to the potentially less resourceful group
who had not complained and who was thus unfairly dis-
advantaged. Among those who had not complained
might have been the most seriously ill. The practice
involved a breach with the principle of justice when the
hospital let its own economic incentives and disincen-
tives override the principle of equal treatment, the med-
ical evaluation of need, and the assessment of severity,
utility and cost-benefit ratios. However, the CEC pointed
out that knowledge about the waiting list patients, and
thus the actual consequences of the priority setting, was
lacking. The CEC recommended that such knowledge
was obtained, and that a system to identify patients
whose deadline was approaching or whose medical con-
dition was worsening while on the waiting list, was
introduced.
Other findings
The number of CEC activities involving priority setting
and resource use increased throughout the period stud-
ied (13 years in total). The three most recent years
(2013-15) saw 45% (35 of 78) of the CEC activities
registered.
Findings also indicate that priority setting and re-
source use have been addressed more often by CECs in
university hospitals than in medium-sized and smaller
hospitals. Thirty-seven (47%) of the 78 activities were
registered in university hospital CECs (comprising eight
of the 37 CECs studied). Most of the discussions related
to particularly resource-intensive treatment such as
costly new drugs or intensive care were raised at univer-
sity hospitals.
We were interested in whether CEC would sometimes
express explicit criticism towards hospital management,
and we found such criticism in five case reports (four
principled/general cases, one individual patient case).
Typically, management was criticised for underfunding
or understaffing of important functions.
Discussion
Wide variation in topics
The results indicate that the Norwegian CECs have
worked with issues of priority setting and resource use
in a variety of ways, identifying such issues in individual
patient cases and principled/general cases referred for
CEC deliberations, and bringing such issues up for
reflection and debate among health professionals in the
hospital in seminars. As some of the examples illustrate,
clinical-ethical cases of this sort might be both import-
ant and highly complex. The issues have appeared more
often in recent years; two possible explanations for this
can be, first, that awareness of priority setting issues in
the healthcare services has increased; second, that recent
years might have seen some new kinds of dilemmas, as
in case D.
The CEC as analyst, advisor and moderator
CEC members are trained in structured analysis of what
is at stake in a clinical-ethical dilemma, emphasizing the
values, moral principles and relevant law involved in the
case. Dilemmas of priority setting and resource use
ought to be no different than other clinical-ethical
dilemmas in this regard, and the CEC can analyse and
provide advice on such cases in light of priority setting
criteria and relevant arguments from ethical debates in
the field.
In addition, CECs emphasize process: as per the ideals
of discourse ethics, CECs aim for stakeholder involve-
ment in the deliberations, either directly (such as in case
A) or by representative [18]. The CEC may thus provide
the kind of structured, transparent and open deliberation
process that some argue is an essential prerequisite for
legitimate priority setting decisions [5].
The CEC might constitute a well-suited forum for pri-
ority setting discussions because contributing knowledge
of ethics, law and medicine, and being broadly consti-
tuted with different professions and user representation.
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Ideally, then, the CEC may play a role in moderating
more just priority decisions; arguably, cases A-E exem-
plify this.
The CEC as disseminator
Several CECs arranged seminars on the 2014 govern-
mental report on priority setting and the framework for
priority setting suggested therein [19]. Others seminars
concerned priority dilemmas affecting specific patient
groups or medical specialities. In such seminars, partici-
pants are exposed to priority setting frameworks and
their rationale, as well as given a forum for discussing
implications for their own practice. Through seminars
the CEC therefore can bring awareness of priority set-
ting issues and knowledge of arguments and principles
to a greater number of clinicians.
In case discussions, once it is agreed that a dilemma
concerns priority setting, the dilemma can be analyzed
within corresponding ethical frameworks and with rele-
vant ethical terms and priority criteria. The CEC might
therefore have an important role in identifying that the
dilemma at hand is a priority setting dilemma, as is illus-
trated in all the example cases (A-E). As health profes-
sionals do not necessarily have other forums for
discussing priority dilemmas, the CEC may play a signifi-
cant role in ensuring that priority setting and resource use
is discussed by clinicians. This may lead to increased
awareness of dilemmas, competence (e.g., knowledge of
priority setting criteria and moral arguments) and open-
ness in clinical priority setting.
The CEC as coordinator
Several of the cases (B, D, E) illustrate the CEC’s role as
a coordinator or facilitator of communication between
individual clinicians and clinical departments on the one
hand, and hospital management and national institutions
responsible for priority setting on the other. In these
cases, the CEC helped identify and formulate the
dilemmas and the values at stake before referring the
case on. They thereby ensured that the dilemmas experi-
enced at the clinical level were raised to a higher level.
Case E also illustrates that concerns may not be taken
sufficiently seriously in the hospital hierarchy when
voiced by individual clinicians; the CEC, however, may
be well positioned to highlight and speak up about prob-
lematic practices.
The CEC as watch dog and guardian
The CEC can act as a stakeholder advocate – a “watch
dog”. In case B, the CEC advocated for the patient’s per-
spective in the appeal process with the responsible office
on the national level. In case A, the CEC turned out to
support the concerns of the health professionals, under-
pinning these with arguments rooted in priority setting
criteria. The CEC’s watch dog role can be important in
promoting more just decisions; especially, arguably, in
ensuring that patients’ right to healthcare is met. Cases
B and C illustrate the CEC supporting groups that may
be relatively neglected in the health services (here, pa-
tients with chronic psychosis and intravenous drug
abuse, respectively). The CEC’s verdict and any advo-
cacy, however, must be based on close weighing of the
moral and medical arguments [20].
Relatedly, in our material there were also several ex-
amples of the CEC acting as a guardian of societal
values. The CEC would sometimes interpret a case and a
proposed line of action as presenting a challenge to
commonly accepted values and moral principles. The
CEC would then have a role in upholding such values,
arguing that the courses of action that best protect these
should be preferred. Case D is an example of this, where
the principle of equality of access was highlighted and
argued to be an overriding concern. The watch dog and
guardian roles may also come into conflict, when, for
instance, the health care needs of a patient or a patient
group is pitted against tenets of professional ethics or
priority setting guidelines.
There are some examples of CECs being willing to
take potentially “unpopular” stances such as recom-
mending against offering treatment for individual pa-
tients or patient groups; cases A and D are examples of
this. In our findings, there are also some examples of the
CEC criticizing departments or hospital management
(e.g., case E).
Are the CECs equipped to handle issues of priority
setting?
In our estimation, cases A-E show the efforts of CECs
being of some help in a set of priority setting dilemmas;
evidently, then, CECs can be helpful in priority setting
issues. However, our investigation was not suited to dir-
ectly assess the quality of the CECs’ work with issues of
prioritization. Thus, we cannot say whether the CECs
actually were of help in the remainder of the cases iden-
tified in the study, or indeed whether they sometimes
did more harm than good. The field of priority setting in
healthcare is complex and requires the CEC to be famil-
iar with priority setting criteria and specialized ethical
debates, as several of the examples illustrate. Case B, for
instance, saw the CEC weighing and adapting general
principles (i.e., national priority setting criteria) to fit the
complexities of an individual patient’s situation in a fair
manner. Most likely such knowledge, some of which
within the ambit of political philosophy, is not as wide-
spread among CEC members as is knowledge of other
aspects of clinical ethics.
There is a need, then, for the CEC to acquire special-
ized knowledge, for instance through tailored courses in
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the ethics of priority setting, or by recruiting at least one
member with such knowledge. Seeing as how clinical-
ethical cases appear more likely to occur at university
hospitals, a case could be made that the most difficult
clinical-ethical cases concerning priority setting should
be handled mainly in university hospital CECs, at least
at the present stage. Such CECs typically have profes-
sional ethicists among their members. However, it is not
ideal to remove discussion from the hospitals in which
the cases will have to be handled. It is also vital that the
local stakeholders are able to participate in the CEC dis-
cussions. Furthermore, CECs in smaller hospitals have
an equally important responsibility in inducing aware-
ness of priority setting issues amongst local clinicians;
this task cannot be transferred to university hospital
CECs.
What authority should the CECs have in such cases? In
Norway, as in many other countries, CECs have no
decision-making authority. The CEC will analyse the case
and provide advice if this is requested; it is then up to the
clinician whether and how to use the CEC’s advice.
If a critic were to question the democratic legitimacy
of a CEC’s handling of priority setting dilemmas then
this would be part of our answer: the CEC does not
make decisions; it only attempts to illuminate the case
and provide advice. However, because only the most
general priority setting decisions can be made at the
legislative level, there is a need for agents “downstream”
to carry on the responsibility of fair priority setting [21].
Increased transparency is called for in priority setting
[5]; CECs promote transparency through presenting the
relevant arguments in written case reports available to
the stakeholders and sometimes to larger audiences.
Arguably, therefore, a CEC deliberation, through being
structured, transparent and open to diverse stakeholder
perspectives, is able to confer not only moral but some
political legitimacy on the conclusion reached.
Strengths and limitations
The study’s strength is that it is a systematic investiga-
tion of the activities of all Norwegian CECs. The limita-
tion is that some of the CEC yearly reports are brief and
selective, without detailing topics and dilemmas, some-
times describing activities by title only. For this reason,
it is likely that some relevant activities have been missed.
In addition, the yearly reports and the case reports are
the CEC’s own descriptions; possibly, the CEC’s roles
and impact would appear in a different light if the expe-
riences of the other stakeholders had also been con-
sulted. From previous research and from our experience
we contend that priority setting and resource use often
figure as relevant considerations in CEC cases without
necessarily being treated as the dominant or decisive
issues [22]. Such issues, then, are likely to have been
addressed in many more CEC cases than the ones iden-
tified in the study. One set of examples would be cases
concerning the limitation of life-prolonging treatment
for severely ill or dying patients, cases commonly ad-
dressed by CECs.
Conclusion
Norwegian hospitals CECs play several potentially valu-
able roles in handling issues of priority setting and
resource use in the health services. Clinical cases involv-
ing such issues may be both important and complex,
and are likely to become more prevalent. In order to ful-
fil their responsibility, CECs thus need knowledge of
both the ethics and the institutionalized systems of pri-
ority setting. There is potential for developing this aspect
of the CECs’ work further. There should be openness
about the CECs’ work, and their handling of cases
should also be evaluated.
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